Bombshell Study: This Drug Can Block Multiple COVID-19 Variants

In a recent study published in Science Immunology, researchers found that the drug diABZI—which activates the body’s innate immune response—was highly effective in preventing severe COVID-19.

The findings suggest that diABZI could also treat other respiratory coronaviruses.

The study is from the University of Pennsylvania. One author is Sara Cherry, Ph.D.

The SARS-CoV-2 virus initially targets epithelial cells in the respiratory tract. As the first line of defense against infection, the respiratory tract’s innate immune system recognizes viral pathogens by detecting their molecular patterns.

Few drugs have been identified as game-changers in blocking SARS-CoV-2 infection. (Read more from “Bombshell Study: This Drug Can Block Multiple COVID-19 Variants” HERE)

Delete Facebook, Delete Twitter, Follow Restoring Liberty and Joe Miller at gab HERE.